BMRN (biomarin.com) Earnings per share growth this year

Official company branding of BioMarin Corp (BMRN)

Annual earnings per share growth demonstrates the resilience of BioMarin Pharmaceutical (BMRN), whose dominance in treating rare pathologies and patent protection safeguard profitability. The value of 68.30 represents the latest metric reading. BioMarin Pharmaceutical (BMRN) is accelerating the release of innovations through partnerships with clinics and laboratories. The defensive nature of the business guarantees stable demand for therapy even during economic downturns.

BMRN (biomarin.com) Earnings per share growth in current year history from 07/04/2022 to 11/15/2026

Financial and market metric breakdowns for biomarin.com (BMRN)

- stock value and consensus price forecast:
Basic company analysis:BioMarin Corp (BMRN)
Manufactured products of BioMarin Pharmaceutical

This indicator measures the annual growth of earnings per share, allowing for an assessment of real capital generation efficiency without market noise. By analyzing the year-over-year volatility of earnings per share, an investor can correlate the scaling rates of BioMarin Pharmaceutical (BMRN) with the commercial success of the drug Voxzogo and the gene therapy's progress toward the break-even point.

Main competitors

Earnings per share growth rate in current year Vertex Pharmaceuticals Inc. (VRTX)|ALNY (Alnylam) - Earnings growth in current year|Earnings per share growth this year INSM (Insmed)|Net earnings per share growth this year UTHR (United Therapeutics Corporation)|BBIO (BridgeBio Pharma) - Earnings per share increase in current year|Earnings growth in current year BGM (BGM Group Ltd)|COGT (Cogent Bio) - Earnings per share trend in current year|Xeris Biopharma - Earnings growth in current year|Earnings per share increase in current year KROS (Keros Therapeutics)|ARCT: Earnings growth in current year|Eton Pharmaceuticals Inc (ETON) - Earnings growth in current year|Earnings per share growth in current year Kamada Corp|FULC: Earnings per share increase in current year|Earnings per share growth in current year Abeona Therapeutics, Inc. (ABEO)|Net earnings per share growth this year Mereo BioPharma Group plc MREO|Earnings per share growth in current year Protalix BioTherapeutics PLX|Earnings growth in current year Pliant Therapeutics PLRX|appliedtherapeutics.com - Earnings growth in current year|Earnings per share increase in current year RNTX (Rein Therapeutics, Inc.)|GELS: Earnings growth in current year|Earnings per share growth rate in current year Aytu BioPharma, Inc. (AYTU)|CMMB (Chemomab Therapeutics Ltd) - Earnings growth in current year|Earnings per share growth this year SRXH (SRx Health Solutions)|Net earnings per share growth this year PLRZ (Polyrizon Ltd)|AEZS - Earnings per share growth rate in current year|Earnings per share growth in current year Cyclo Therapeutics Inc. CYTH|Inozyme Pharma, Inc. (INZY) - Earnings per share growth rate in current year|RPHM: Net earnings per share growth this year|Earnings per share growth rate in current year COSCIENS Biopharma Inc